Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies
Richard F. Olsson(AstraZeneca (Netherlands)), Kenneth R. Cooke(Johns Hopkins University), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Vincent T. Ho(Dana-Farber Cancer Institute), Hillard M. Lazarus(University Hospitals of Cleveland), Christopher C. Dvorak(University of California, San Francisco), Xiaochun Zhu, Vikas Gupta(Indian Institute of Technology Kanpur), Sonali Chaudhury(Northwestern University), Marcelo C. Pasquini(Cleveland Clinic), Görgün Akpek(Banner MD Anderson Cancer Center), J R Schriber(Arizona Oncology), Brian J. Bolwell(Cleveland Clinic), Olle Ringdén(Karolinska Institutet), D I Marks, Christopher Bredeson
Cited by 144
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
|New England Journal of Medicine|2011|1.1k
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
|New England Journal of Medicine|2002|986